Intimation of receipt of certified true copy of merger from Hon''ble NCLT Mumbai.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innovassynth Investments Limited, a BSE-listed entity (scrip code 533315), has received the certified true copy of the NCLT Mumbai orders approving the merger by absorption of Innovassynth Technologies (India) Limited (Transferor, an unlisted operating company in specialty chemicals and pharma intermediates) into itself (Transferee). The NCLT passed the Final Order on November 14, 2025, and a Rectification Order on November 26, 2025 to fix typographical errors. Under the scheme, the share swap ratio is 1:1, meaning one equity share of Rs. 10 in Innovassynth Investments will be issued for every one share held in Innovassynth Technologies. The Appointed Date is October 1, 2024. Upon effectiveness, Innovassynth Technologies will be dissolved without winding up, and Innovassynth Investments will be renamed 'Innovassynth Technologies (India) Limited'. The merger was approved by 100% of shareholders of the Transferor and over 95% of shareholders of the Transferee. The scheme will become effective once the certified copies are filed with the Registrar of Companies, Mumbai.
Once filed with the RoC, the operating specialty chemicals business will vest in the listed entity, making it the surviving operating company under the name Innovassynth Technologies (India) Limited. Shareholders of the listed entity should expect a name change on BSE records and the addition of an operating chemicals business to the entity's portfolio, though no open offer is triggered given the related-party nature of the merger.